Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case-control study.
du Cheyron D, Bouchet B, Bruel C, Daubin C, Ramakers M, Charbonneau P
Crit Care 2006, 10:R45
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research    
Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates
Oudemans-van Straaten HM, van Schilfgaarde M, Molenaar PJ, Wester JPJ, Leyte A
Critical Care 2009, 13:R193 (3 December 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
2.


Review    
Clinical review: Patency of the circuit in continuous renal replacement therapy
Joannidis M, Oudemans-van Straaten HM
Critical Care 2007, 11:218 (12 July 2007)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
3.


Research    
Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis
Gonano C, Sitzwohl C, Meitner E, Weinstabl C, Kettner SC
Critical Care 2006, 10:R160 (15 November 2006)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
4.


Research    
The effects of continuous venovenous hemofiltration on coagulation activation
Bouman CSC, de Pont ACJM, Meijers JCM, Bakhtiari K, Roem D, Zeerleder S, Wolbink G, Korevaar JC, Levi M, de Jonge E
Critical Care 2006, 10:R150 (27 October 2006)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.